Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
United Therapeutics Corporation
Director
Mattel Inc.
Director
Ares Management Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 30, 2026 | Ares Management Corporation | Grant or award | +1,728 | — | — |
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +1,310 | — | — |
| May 15, 2026 | Mattel Inc. | Option exercise | +8,594 | — | — |
| Mar 23, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $530.00 | $106,000 |
| Mar 16, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $535.44 | $107,088 |
| Mar 6, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $510.00 | $102,000 |
| Feb 27, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $509.55 | $101,910 |
| Feb 20, 2026 | Ares Management Corporation | Open-market purchase | +480 | $124.43 | $59,726 |
| Sep 19, 2025 | United Therapeutics Corporation | Open-market sale | −1,800 | $415.43 | $747,774 |
| Jul 31, 2025 | Ares Management Corporation | Grant or award | +1,166 | — | — |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +1,190 | — | — |
| May 23, 2025 | Mattel Inc. | Option exercise | +6,843 | — | — |
| Dec 12, 2024 | Ares Management Corporation | Gift | −397 | — | — |
| Nov 11, 2024 | United Therapeutics Corporation | Open-market sale | −1,750 | $412.48 | $721,840 |
| Sep 17, 2024 | United Therapeutics Corporation | Option exercise | +2,300 | $112.14 | $257,922 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.